Owen McCarty: The Potential Benefit of Targeting FXI in Sepsis
Owen McCarty, Professor and Chair at Oregon Health and Science University, shared a post on LinkedIn:
“Our recent preclinical work highlighting the potential benefit of targeting FXI in sepsis. Led by Robert Silasi and Ravi Shankar Keshari, Ph.D with Aleksandr Shamanaev, Samantha (Sami) Moellmer, Cristina Puy Garcia, PhD, Joseph Shatzel, and Florea Lupu.”
Title: Protective effects of factor XI inhibition by abelacimab in a baboon model of live Staphylococcus aureus sepsis
Authors: Robert Silasi, Ravi S. Keshari, Tomohiro Abe, Stephanie D. Byrum, Girija Regmi, Cristina Lupu, Constantin Georgescu, Joe H. Simmons, Aleksandr Shamanaev, Samantha A. Moellmer, Cristina Puy, Joseph J. Shatzel, Dennis Province, Rick D. Edmondson, Samuel G. Mackintosh, Nathan L. Avaritt, Dan Bloomfield, David Gailani, Alan J. Tackett, Owen J.T. McCarty, Florea Lupu
Read full artile here.
Stay updated with Hemostasis Today.
-
Apr 13, 2026, 08:35Sara Altayeb: ESC 2026 Clinical Pearls for Bleeding on Anticoagulation
-
Apr 13, 2026, 07:58The Case for Greater Investment in VTE Research – JTH
-
Apr 13, 2026, 07:44Mattia Galli: A Clinicial Guide to Navigating Bleeding on Anticoagulant Therapy
-
Apr 13, 2026, 07:31Explore the Power of Guidelines in Hemophilia Care – EAHAD
-
Apr 13, 2026, 06:57Heghine Khachatryan: Why PNH Is More Than a Hemolytic Disease
-
Apr 13, 2026, 05:43Wolfgang Miesbach: A Historic Experiment That Changed Our Understanding of ITP
-
Apr 13, 2026, 04:49Danielle Boyle: This Consultation Is an Opportunity for The Entire ITP Community to Be Heard
-
Apr 13, 2026, 04:18Stephen Cornelissen: You Might Be Eligible to Donate Blood – Here’s Why It’s Worth Checking
-
Apr 13, 2026, 04:12Angie Read: A Powerful Conversation on Survival, Recovery, and Purpose on Stroke Sisters’ Latest Episode